These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 25572843)
1. Positive feedback regulation of type I interferon by the interferon-stimulated gene STING. Ma F; Li B; Yu Y; Iyer SS; Sun M; Cheng G EMBO Rep; 2015 Feb; 16(2):202-12. PubMed ID: 25572843 [TBL] [Abstract][Full Text] [Related]
2. Impacts of the STING-IFNAR1-STAT1-IRF1 pathway on the cellular immune reaction induced by fractionated irradiation. Du J; Kageyama SI; Yamashita R; Hirata H; Hakozaki Y; Okumura M; Motegi A; Hojo H; Nakamura M; Hirano Y; Sunakawa H; Minamide T; Kotani D; Tanaka K; Yano T; Kojima T; Ohashi A; Tsuchihara K; Akimoto T Cancer Sci; 2022 Apr; 113(4):1352-1361. PubMed ID: 35133062 [TBL] [Abstract][Full Text] [Related]
3. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING. Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343 [TBL] [Abstract][Full Text] [Related]
4. Modulation of Stimulator of Interferon Genes (STING) Expression by Interferon-γ in Human Keratinocytes. Nishikawa Y; Matsuzaki Y; Kimura K; Rokunohe A; Nakano H; Sawamura D Biochem Genet; 2018 Apr; 56(1-2):93-102. PubMed ID: 29143896 [TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms of human STING can affect innate immune response to cyclic dinucleotides. Yi G; Brendel VP; Shu C; Li P; Palanathan S; Cheng Kao C PLoS One; 2013; 8(10):e77846. PubMed ID: 24204993 [TBL] [Abstract][Full Text] [Related]
6. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells. Vasiyani H; Shinde A; Roy M; Mane M; Singh K; Singh J; Gohel D; Currim F; Vaidya K; Chhabria M; Singh R Apoptosis; 2021 Jun; 26(5-6):293-306. PubMed ID: 33840002 [TBL] [Abstract][Full Text] [Related]
7. Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression. Nazmi A; Field RH; Griffin EW; Haugh O; Hennessy E; Cox D; Reis R; Tortorelli L; Murray CL; Lopez-Rodriguez AB; Jin L; Lavelle EC; Dunne A; Cunningham C Glia; 2019 Jul; 67(7):1254-1276. PubMed ID: 30680794 [TBL] [Abstract][Full Text] [Related]
8. Binding of Duck Tembusu Virus Nonstructural Protein 2A to Duck STING Disrupts Induction of Its Signal Transduction Cascade To Inhibit Beta Interferon Induction. Zhang W; Jiang B; Zeng M; Duan Y; Wu Z; Wu Y; Wang T; Wang M; Jia R; Zhu D; Liu M; Zhao X; Yang Q; Wu Y; Zhang S; Liu Y; Zhang L; Yu Y; Pan L; Chen S; Cheng A J Virol; 2020 Apr; 94(9):. PubMed ID: 32075929 [TBL] [Abstract][Full Text] [Related]
9. Functional crosstalk between type I and II interferon through the regulated expression of STAT1. Gough DJ; Messina NL; Hii L; Gould JA; Sabapathy K; Robertson AP; Trapani JA; Levy DE; Hertzog PJ; Clarke CJ; Johnstone RW PLoS Biol; 2010 Apr; 8(4):e1000361. PubMed ID: 20436908 [TBL] [Abstract][Full Text] [Related]
13. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Liu Y; Zhang Z; Zhao X; Yu R; Zhang X; Wu S; Liu J; Chi X; Song X; Fu L; Yu Y; Hou L; Chen W Viral Immunol; 2014 Aug; 27(6):267-76. PubMed ID: 24905060 [TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells. Urin V; Shemesh M; Schreiber G J Mol Biol; 2019 Aug; 431(17):3324-3338. PubMed ID: 31207241 [TBL] [Abstract][Full Text] [Related]
16. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus. Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ Front Immunol; 2018; 9():1297. PubMed ID: 29963044 [TBL] [Abstract][Full Text] [Related]
17. Cyclic Dinucleotides Inhibit Osteoclast Differentiation Through STING-Mediated Interferon-β Signaling. Kwon Y; Park OJ; Kim J; Cho JH; Yun CH; Han SH J Bone Miner Res; 2019 Jul; 34(7):1366-1375. PubMed ID: 30779854 [TBL] [Abstract][Full Text] [Related]
18. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. Deng L; Liang H; Xu M; Yang X; Burnette B; Arina A; Li XD; Mauceri H; Beckett M; Darga T; Huang X; Gajewski TF; Chen ZJ; Fu YX; Weichselbaum RR Immunity; 2014 Nov; 41(5):843-52. PubMed ID: 25517616 [TBL] [Abstract][Full Text] [Related]
19. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling. Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229 [TBL] [Abstract][Full Text] [Related]
20. A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment. Nagata M; Kosaka A; Yajima Y; Yasuda S; Ohara M; Ohara K; Harabuchi S; Hayashi R; Funakoshi H; Ueda J; Kumai T; Nagato T; Oikawa K; Harabuchi Y; Esteban C; Ohkuri T; Kobayashi H Cancer Immunol Immunother; 2021 Aug; 70(8):2301-2312. PubMed ID: 33507344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]